Your session is about to expire
← Back to Search
blood flow restriction for Anterior Cruciate Ligament Injury
Study Summary
This trial will test whether adding PBFR to PT can improve outcomes for people who've had ACL surgery.
- Anterior Cruciate Ligament (ACL) Injury
- Anterior Cruciate Ligament Injury
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are enrollees currently being accepted for this clinical trial?
"Affirmative. On clinicaltrials.gov, information regarding the current status of this trial is available. As of April 18th 2022, it has been recruiting participants and aiming to enrol 25 patients at one site."
Does my profile meet the criteria for this research endeavor?
"To qualify for this trial, prospective patients must have anterior cruciate ligament tear and fall between 18 to 34 years of age. It is also estimated that 25 participants are required in total."
Is the age criterion for participation in this clinical trial strict or is it open to participants of all ages?
"The primary demographic of this trial is comprised of 18 to 34 year-olds. For those outside the age range, there are 47 studies for minors and 25 options for elderly patients."
How many individuals are participating in the experiment?
"Affirmative, the clinical trial is open for enrollment. It was listed on April 18th 2022 and last updated that same day. The study hopes to enrol 25 people at a single medical site."
Share this study with friends
Copy Link
Messenger